A common medication may have an unexpected effect on a serious eye condition, new research suggests.

Shares of Aldeyra Therapeutics ALDX plunged 70.7% on Tuesday after the company announced receiving a Complete Response Letter ...

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third ...

If you have dry eye, you know how uncomfortable it can be. Dry eye disease happens when your eyes do not make enough quality tears or when your tears dry out too quickly. This can lead to eye ...

Severe, chronic dry eye or dry eye disease (DED) can persist for a long time and may resist standard treatments. It can happen when tear production is low or when tear flow is blocked. Severe dry eye ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

Spring eye allergy season has already begun across the San Fernando Valley, and many residents may be mistaking allergy-related symptoms for other eye conditions that require different treatment, ...

Thyroid eye disease can cause eye pain, dryness, and eyelids that do not fully close. These symptoms can disrupt sleep. When your eyes stay partly open at night, light and dryness can make it harder ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...